The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hiren Kirankumar Mala

pdf

Trans India House Impex Ltd.

11 Feb 2025

13.78

-4.97%

Company Update

Trans India House Impex Ltd - 523752 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Disclosure under Regulation 30 of SEBI (LODR) Regulation, 2015 - Newspaper Publication.

pdf

Trans India House Impex Ltd.

10 Feb 2025

13.78

-4.97%

Corp. Note

Trans India House Impex Ltd - 523752 - Integrated Filing (Financial)

BSE India

We are submitting herewith the Integrated Filing (Financial) for the Quarter and Nine- month period ended 31st December, 2024.

pdf

Trans India House Impex Ltd.

10 Feb 2025

13.78

-4.97%

Result

Trans India House Impex Ltd - 523752 - Financial Results - Un-Audited Standalone Financial Results For …

BSE India

Financial Results for the Quarter and Nine Months period ended 31st December 2025.

pdf

	Dec 2024	Sep 2024	Dec 2023	Change QoQ%	Change YoY%
Total Revenue Qtr	15.75	12.02	26.27	31.0%	-40.0%
Operating Profit Qtr	0.35	0.61	-0.16	-42.6%	318.8%
Net Profit Qtr	0.05	0.46	0.26	-89.1%	-80.8%
Earning Per Share Adjusted latest Qtr	0.01	0.13	0.07	-92.3%	-85.7%

* Standalone data

Detailed Results

Trans India House Impex Ltd.

10 Feb 2025

13.78

-4.97%

Board Meeting

Trans India House Impex Ltd - 523752 - Board Meeting Outcome for 10/02/2025

BSE India

Outcome of Board Meeting dated 10th February 2025.

pdf

Trans India House Impex Ltd.

07 Feb 2025

13.78

-4.97%

Company Update

Trans India House Impex Ltd - 523752 - Announcement under Regulation 30 (LODR)-Meeting Updates

BSE India

Outcome of Meeting of Rights Issue committee.

pdf

Trans India House Impex Ltd.

25 Jan 2025, 03:25PM

13.78

-4.97%

Board Meeting

Trans India House Impex Ltd - 523752 - Board Meeting Intimation for 10/02/2025

BSE India

Trans India House Impex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 ,inter alia, to consider and approve Un-Audited Standalone Financial Results of the Company for the Quarter and Nine months period ended December 31, 2024 any other matter with the permission of Chair.

pdf